| 1 |
Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers |
|
|
| Muzamil Khawaja, Janki Thakker, Riyad Kherallah, Masafumi Kitakaze, Hani Jneid, Dominick J. Angiolillo, Yochai Birnbaum |
|
| Cardiovascular Drugs and Therapy. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters |
|
|
| Kelly Bleasby, Robert Houle, Michael Hafey, Meihong Lin, Jingjing Guo, Bing Lu, Rosa I. Sanchez, Kerry L. Fillgrove |
|
| Viruses. 2021; 13(8): 1566 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing Observational Study |
|
|
| José María Remes-Troche,Sergio Sobrino-Cossío,Julio César Soto-Pérez,Oscar Teramoto-Matsubara,Miguel Morales-Arámbula,Antonio Orozco-Gamiz,José Luis Tamayo de la Cuesta,Gualberto Mateos |
|
| Clinical Drug Investigation. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
ADP-Receptor Inhibitors in the Perioperative Period: The Good, the Bad, and the Ugly |
|
|
| Adriana Dana Oprea,Wanda M. Popescu |
|
| Journal of Cardiothoracic and Vascular Anesthesia. 2013; 27(4): 779 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Recent Safety Concerns With Proton Pump Inhibitors |
|
|
| Joan Chen,Yuhong Cathy Yuan,Grigorios I. Leontiadis,Colin W. Howden |
|
| Journal of Clinical Gastroenterology. 2012; 46(2): 93 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors |
|
|
| Chun Shing Kwok,Yoon Kong Loke |
|
| Expert Opinion on Drug Safety. 2012; 11(2): 275 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
The risks of PPI therapy |
|
|
| Paul Moayyedi,Grigorios I. Leontiadis |
|
| Nature Reviews Gastroenterology & Hepatology. 2012; 9(3): 132 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors |
|
|
| Kwok, C.S., Loke, Y.K. |
|
| Expert Opinion on Drug Safety. 2012; 11(2): 275-284 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
The risks of PPI therapy |
|
|
| Moayyedi, P., Leontiadis, G.I. |
|
| Nature Reviews Gastroenterology and Hepatology. 2012; 9(3): 132-139 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Recent safety concerns with proton pump inhibitors |
|
|
| Chen, J., Yuan, Y.C., Leontiadis, G.I., Howden, C.W. |
|
| Journal of Clinical Gastroenterology. 2012; 46(2): 93-114 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Anti-platelet therapy for acute coronary syndrome: A review of currently available agents and what the future holds |
|
|
| Syed, F.A., Bett, J.H.N., Walters, D.L. |
|
| Cardiovascular and Hematological Disorders - Drug Targets. 2011; 11(2): 79-86 |
|
| [Pubmed] [Google Scholar] |
|
